Comparison of continuous and intermittent anorectic therapy in obesity.
Open accessIntegrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Costs potentially could be reduced by less frequent dosing (e.g., every other week), as suggested with other medications.
“Costs potentially could be reduced by less frequent dosing (e.g., every other week), as suggested with other medications [118]”
From The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities (2023) · cites this paper as [118]
Cites
Treatment of refractory obesity with fenfluramine.
Munro, J., Seaton, D., & Duncan, L. J. P. (1966) · BMJ · doi:10.1136/bmj.2.5514.624 · Cited by 76 · see citing works
Self-citationThe Long‐Term Management of Obesity in General Practice
Silverstone, J. T., & Solomon, T. (1965) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1965.tb03144.x · Cited by 48 · see citing works
Diethylpropion in the Treatment of "Refractory" Obesity
Seaton, D., Duncan, L. J. P., Rose, K., & Scott, A. M. (1961) · BMJ · doi:10.1136/bmj.1.5231.1009 · Cited by 46 · see citing works
Self-citationPHENMETRAZINE HYDROCHLORIDE AND METHYLCELLULOSE IN THE TREATMENT OF "REFRACTORY" OBESITY
Duncan, L. J. P., Rose, K. O., & Meiklejohn, A. P. (1960) · The Lancet · doi:10.1016/s0140-6736(60)92249-2 · Cited by 43 · see citing works
Self-citationObesity in childhood. A controlled trial of anorectic drugs.
Lorber, J. (1966) · Archives of Disease in Childhood · doi:10.1136/adc.41.217.309 · Cited by 35 · see citing works
SEATON, D. A., Rose, K. O., & Duncan, L. J. P. (1964) · PubMed · Cited by 13 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914 · see citing works
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934 · see citing works
Long-term Drug Treatment for Obesity: A Systematic and Clinical Review
Yanovski, S. Z., & Yanovski, J. A. (2014) · JAMA · doi:10.1001/jama.2013.281361 · Cited by 876 · see citing works
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842 · see citing works
Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J. (2003) · JAMA · doi:10.1001/jama.289.12.1537 · Cited by 511 · see citing works
Bray, G. A., Hollander, P., Klein, S., Kushner, R., Levy, B., Fitchet, M., & Perry, B. H. (2003) · Obesity Research · doi:10.1038/oby.2003.102 · Cited by 344 · see citing works
AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity
Grunvald, E., Shah, R., Hernaez, R., Chandar, A. K., Pickett-Blakely, O., Teigen, L. M., Harindhanavudhi, T., Sultan, S., Singh, S., & Davitkov, P. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.08.045 · Cited by 347 · see citing works
AGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274 · see citing works
Pharmacotherapy of obesity: available medications and drugs under investigation.
Pilitsi, E., Farr, O. M., Polyzos, S. A., Perakakis, N., Nolen-Doerr, E., Papathanasiou, A.-E., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.10.010 · Cited by 248 · see citing works
Centrally Acting Agents for Obesity: Past, Present, and Future
Coulter, A. A., Rebello, C. J., & Greenway, F. L. (2018) · Drugs · doi:10.1007/s40265-018-0946-y · Cited by 151 · see citing works
Long-Term Weight Loss Strategies for Obesity
Kheniser, K., Saxon, D. R., & Kashyap, S. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab091 · Cited by 139 · see citing works
Wadden, T. A., Chao, A. M., Moore, M., Tronieri, J. S., Gilden, A., Amaro, A., Leonard, S., & Jakicic, J. M. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00534-z · Cited by 129 · see citing works
Drug Treatment of the Overweight Patient
Bray, G. A., & Ryan, D. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.053 · Cited by 115 · see citing works
Kim, K. K., Cho, H.-J., Kang, H.-C., Youn, B.-B., & Lee, K.-R. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.5.614 · Cited by 88 · see citing works
Combination phentermine and topiramate extended release in the management of obesity.
Alfaris, N., Minnick, A. M., Hopkins, C. M., Berkowitz, R. I., & Wadden, T. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1041505 · Cited by 38 · see citing works
Greater hunger and less restraint predict weight loss success with phentermine treatment
Thomas, E. A., Mcnair, B., Bechtell, J. L., Ferland, A., Cornier, M., & Eckel, R. H. (2016) · Obesity · doi:10.1002/oby.21244 · Cited by 30 · see citing works
“Studies on the effect of phentermine alone on weight reduction have shown a mean weight loss of 5% over a short-term period (no studies of safety or efficacy beyond 1 year have been done) (9-12).”
BackgroundEpidemiology of Obesity and Pharmacologic Treatment Options
Shettar, V., Patel, S., & Kidambi, S. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617713189 · Cited by 26 · see citing works
Elhag, W., El Ansari, W., Abdulrazzaq, S., Elsherif, M., & Mustafa, I. (2019) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2019.07.024 · Cited by 15 · see citing works
- Authors
- Munro, J. F., MacCuish, A. C., Wilson, E. M., & Duncan, L. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1968-02-10
- Volume
- 1
- Issue
- 5588
- Pages
- 352-354
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC1984840
- OpenAlex
- W2153395253
- Cited by
- 215
- References
- 6
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 6 · 2018: 9 · 2017: 6 · 2016: 11 · 2015: 10 · 2014: 5 · 2013: 12 · 2012: 3
- FWCI
- 1.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- obesity, appetite suppressants, weight loss
- MeSH terms
- Adult, Appetite Depressants, Double-Blind Method, Female, Humans, Middle Aged, Obesity, Phentermine, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
